Nivatrotamab (Anti-CD3 & GD2)
Product Specifications
Synonyms
Hu3F8-BsAb
SKU
C00926-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Nivatrotamab is a humanized bispecific antibody targeting GD2 on tumor cells and CD3 on T cells to enhance immune activation. It is being developed for the treatment of metastatic small cell lung cancer (SCLC) by recruiting T cells to attack tumors. M. W 200.96 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
